According to a new report from Intel Market Research, the global Actonel (Risedronic Acid) market was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.68 billion by 2034, growing at a steady CAGR of 5.2% during the forecast period (2026-2034). This growth is driven by increasing osteoporosis prevalence among aging populations worldwide and rising awareness about bone health...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek